Serum profile of bile acids in COVID-19

Serum profile of bile acids in COVID-19 - SeProBACov

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00024622

Enrollment

Registered

2021-02-19

Start date

2021-02-22

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID- 19

Interventions

Group 1: critically ill patients suffering from COVID-19 Serial blood samples at three points in time within 10 days during the course of the disease and determination of the concentration of 15 indiv

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Female, male and diverse patients • Age> 18 years • (critical) COVID-19 disease (= need for ICU treatment) • Treatment in the COVID-19 intensive care units of the University Medical Center Göttingen

Exclusion criteria

Exclusion criteria: • Age <18 years • Lack of consent • Refusal to participate in the study • Positive SARS-CoV-2 test without COVID-19 disease

Design outcomes

Primary

Measure	Time frame
Bile acids in the serum at different times in the course of the disease (observationell / descriptive)	—

Countries

Germany

Contacts

Public ContactLars-Olav Harnisch

Universitätsmedizin Göttingen Klinik für Anästhesiologie

lars-olav.harnisch@med.uni-goettingen.de05513963579

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026